Shengjiang Tu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shengjiang Tu

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Translational Vision Science & Technology|September 23, 2022

SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic RetinopathyHuy Nguyen, Hui Chen, Meghah Vuppalapaty, et al.

Stem Cell Reports|September 25, 2020

Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to PluripotencySimon E Vidal, Alexander Polyzos, Kaushiki Chatterjee, et al.

Nature Communications|June 1, 2021

Development of selective bispecific Wnt mimetics for bone loss and repairTristan W Fowler, Troy L Mitchell, Claudia Y Janda, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Translational Vision Science & Technology|September 23, 2022

SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic RetinopathyHuy Nguyen, Hui Chen, Meghah Vuppalapaty, et al.

Stem Cell Reports|September 25, 2020

Context-Dependent Requirement of Euchromatic Histone Methyltransferase Activity during Reprogramming to PluripotencySimon E Vidal, Alexander Polyzos, Kaushiki Chatterjee, et al.

Nature Communications|June 1, 2021

Development of selective bispecific Wnt mimetics for bone loss and repairTristan W Fowler, Troy L Mitchell, Claudia Y Janda, et al.

Pageof 2